SCHEMBL6596468

SCHEMBL6596468

COc1ccc(-n2cnnn2)cc1C(=O)N(C)CC(CCN1CCCN(c2nc3ccccc3n2CC(F)(F)F)CC1)c1ccc(F)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR2 P21452 4/20 0.34
KDM4E B2RXH2 1/20 0.34
MAPT P10636 3/20 0.33
LMNA P02545 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
DRD2 P14416 1/20 0.33
DRD4 P21917 1/20 0.33
DRD3 P35462 1/20 0.33
TSHR P16473 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MEN1 O00255 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C19 P33261 1/20 0.32
KMT2A Q03164 1/20 0.32
CYP2D6 P10635 1/20 0.32
CHRM1 P11229 1/20 0.32
HRH1 P35367 1/20 0.32
KCNJ1 P48048 1/20 0.32
KCNH2 Q12809 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6597713 0.93 CHRM1 (0.33) TACR2CHRM1HRH1KCNH2
SCHEMBL6598788 0.93 TACR2 (0.34) TACR2KDM4EMAPTLMNATDP1
SCHEMBL6590639 0.93 TACR2 (0.44) TACR2
SCHEMBL6594885 0.93 HRH1 (0.41) TACR2CYP2D6CHRM1HRH1KCNH2
SCHEMBL6593690 0.92 DRD2 (0.36) TACR2DRD2DRD4DRD3
SCHEMBL6598208 0.92 CHRM1 (0.37) TACR2CHRM1HRH1KCNH2
SCHEMBL6597082 0.92 MEN1 (0.34) TACR2KDM4EMAPTLMNATDP1
SCHEMBL6598374 0.91 TACR2 (0.34) TACR2KDM4EMAPTLMNATDP1
SCHEMBL6598377 0.91 TACR2 (0.34) TACR2KDM4EMAPTLMNATDP1
SCHEMBL6599290 0.90 MAPT (0.34) TACR2KDM4EMAPTLMNATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0888338-B1 NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL) 1,4]DIAZEPAN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES AVENTIS PHARMA INC (US) 2004-11-17 EP disclosed